ISPOR Europe is on the horizon and we’ll be exhibiting four posters at stand C2-027, and Mark Larkin, CEO, will be speaking at an educational symposium.
This year’s conference will focus on the role of health economics and outcomes research science in shaping policy – a perfect opportunity to discuss our capabilities and explore how we can help you to launch and run patient-centered outcomes research and real-world studies. Get in touch to book a meeting with us!
When we’ll be presenting:
Educational symposium: How can we shape HTA with real-world evidence to encourage rare disease
Poster presentation: Caregiver burden in growth hormone deficiency: a targeted review
Meet our attending team:
Mark Larkin, CEO
Amber Kudlac, Director, Analytics
Sam Llewellyn, Associate Director
Anna Richards, Head of Commercial
Akosua Ofori , Associate Consultant
Octavia Borecka, Research Associate
Selcan Altug, Business Development Executive
For more information about the conference, please visit: https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-europe-2023